Clinical TrialsSearch results
Number of results: 894
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Not yet recruiting
- Multidisciplinary Approach after Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure
- Atrial fibrillation
- Yagishita Atsuhiko
- 2023-12-06
Completed
- Edoxaban Versus Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone TAVI - In Atrial Fibrillation
- Atrial Fibrillation
- Watanabe Yusuke
- 2019-02-21
Other
- A Randomized Study of Angiotensin II Type 1 Receptor Blocker vs Dihydropidine Ca Antagonist for Treatment of Paroxysmal Atrial Fibrillation in Patients with Hypertension
- Atrial Fibrillation with Hypertension
- The J-RHYTHM II Investigators
- 2006-07-10
Other
- A study to evaluate Patisiran in patients with transthyretin-type amyloidosis with cardiomyopathy (ATTR amyloidosis with cardiomyopathy)
- ATTR amyloidosis with cardiomyopathy
- Alnylam Pharmaceuticals, Inc
- 2021-05-12
Other
- A multicenter randomized controlled trial of steroid maintenance therapy for preventing relapse of autoimmune pancreatitis.
- Autoimmune pancreatitis
- Division of Gastroenterology, Tohoku University Graduate School of Medicine
- 2009-03-31
Other
- Randamised phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resectable bile duct cancer
- Bile duct cancer
- Nagoya Surgery Support Organization
- 2007-09-10
Recruiting
- A study to test whether BI 907828 helps people with cancer in the biliary tract or pancreas
- Biliary tract adenocarcinoma, pancreatic ductal adenocarcinoma, or other selected solid tumours
- Ogawa Shintaro
- 2022-10-22
Recruiting
- Exploratory study of biomarkers associated with "Phase III study of gemcitabine, cisplatin plus S-1 combination therapy versus gemcitabine, cisplatin plus immune checkpoint inhibitor combination therapy in advanced biliary tract cancer"
- biliary tract cancer
- Sasada Tetsuro
- 2024-09-05
Recruiting
- Necitumumab and Gemcitabine combination therapy for advanced Biliary tract cancer with EGFR Amplification phase2 Trial
- biliary tract cancer
- Sugimori Makoto
- 2023-07-27
Other
- Randomized phase II study of gemcitabine and S-1 combination therapy versus S-1 in advanced biliary tract cancer. (JCOG 0805)
- biliary tract neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2009-02-04